A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2011
11/16/2011	CN102018781B Tissue-regeneration liniment of coptis and forsythia and preparation method thereof
11/16/2011	CN101983661B Traditional Chinese medicine for treating psoriasis
11/16/2011	CN101979086B Chinese medicinal preparation for treating dermatophytosis
11/16/2011	CN101953995B Keloid shrinking ointment
11/16/2011	CN101856455B Chinese medicament for treating psoriasis vulgaris
11/16/2011	CN101829208B Medicinal line for treating anus diseases and preparation method and application thereof
11/16/2011	CN101780173B Detoxifying and dampness-eliminating soup for treating infantile eczema and preparation method thereof
11/16/2011	CN101780037B Dipyridamole self-emulsifying medicament administration system and preparation method thereof
11/16/2011	CN101756906B Pharmaceutical composition of cefcapene pivoxil hydrochloride granules and preparation method thereof
11/16/2011	CN101721527B Traditional Chinese medicine jewelry cream and preparation method thereof
11/16/2011	CN101578091B Composition for external application to skin
11/16/2011	CN101543565B Chinese medicine external-use preparation medicament for treating surgery wound infection and method for producing the same
11/16/2011	CN101474284B External use medicament for treating fungal dermatopathy
11/16/2011	CN101461934B Application of small-molecule peptide in preparing medicament and food for promoting wound healing after operation
11/16/2011	CN101461859B Method for controlling quality of anti-inflammation antibacterial medicament
11/16/2011	CN101385855B Fine purification method of polyvalent anti-snake venom freeze-dry blood serum
11/16/2011	CN101357144B Selaginella uncinata extraction, its preparation method and application
11/16/2011	CN101287457B Use of treprostinil to treat neuropathic diabetic foot ulcers
11/16/2011	CN101199786B Medicinal oil medicament for treating psoriasis
11/16/2011	CN101194974B Exterior washing medicament for treating impetigo
11/16/2011	CN101185736B Orally-administered traditional Chinese medicine for treating acute lupus erythematosus
11/16/2011	CN101167897B Whitening and speckle-removing traditional Chinese medicinal beverage and preparation method thereof
11/16/2011	CN101128193B Anti-radical agents
11/16/2011	CN101121753B Human serum albumin recombination fusion protein with continuous repairing function to multifarious skin cell
11/16/2011	CN101102758B Thyroid hormone analogs for promoting angiogenesis
11/16/2011	CN101084000B External skin agent comprising modified clay for preventing inflammation
11/16/2011	CN101068826B Potent LNA oligonucleotides for the inhibition of HIF-1A expression
11/16/2011	CN101005846B Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase
11/15/2011	US8058445 Substituted pyridinecarboxamides for the treatment of cancer
11/15/2011	US8058426 Phosphorus-containing compounds and uses thereof
11/15/2011	US8058344 Glycodendrimers having biological activity
11/15/2011	US8058282 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy
11/15/2011	US8058280 Substituted thieno[2,3-d]pyrimidin-2,4-dione compounds and uses thereof
11/15/2011	US8058249 Immunostimulatory nucleic acid molecules
11/15/2011	US8058239 HMGB1 protein inhibitorsand/or antagonists for the treatment of vascular diseases
11/15/2011	US8058227 Method of treating fibrosis in a subject in need thereof comprising administering a composition comprising a CSD
11/15/2011	US8058025 Methods for determining efficacy of chemotherapeutic agents
11/15/2011	US8057825 Krill extracts for treatment of cardiovascular diseases
11/15/2011	US8057789 Hematopoietic stem cell culture for use in treatment of blood disorders; regenerative medicine; tissue engineering
11/15/2011	CA2479126C Combination treatments for chemokine-mediated diseases
11/15/2011	CA2449403C Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
11/15/2011	CA2444282C Preparation for hair and/or scalp
11/15/2011	CA2385736C Mediators of hedgehog signaling pathways, compositions and uses related thereto
11/15/2011	CA2267197C Isolation and use of motoneuronotrophic factors
11/15/2011	CA2171761C Eotaxin: eosinophil chemotactic cytokine
11/10/2011	WO2011140337A2 Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof
11/10/2011	WO2011140236A2 Triamcinolone acetonide formulations for treating dermatitis and psoriasis
11/10/2011	WO2011140224A1 Extracts of southernwood and topical uses thereof
11/10/2011	WO2011139794A2 A composition for skin sanitization and protection and method of its use
11/10/2011	WO2011139420A2 Propynylaminoindan transdermal compositions
11/10/2011	WO2011139387A1 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
11/10/2011	WO2011139348A2 Uses of phospholipid conjugates of synthetic tlr7 agonists
11/10/2011	WO2011139168A1 Immunostimulatory compositions and methods of use thereof
11/10/2011	WO2011138364A1 Topical composition and use thereof for the prophylaxis and the treatment of defects connected to inflammatory dermopathies
11/10/2011	WO2011137503A1 Methods for preparing ruthenium phosphine complexes with a structure containing picolinate and/or diimine and/or biphosphine ions, ruthenium phosphine complexes obtained by these methods and uses thereof
11/10/2011	WO2011110918A8 Composition comprising probiotic bacteria for use in the treatment of immune disorders
11/10/2011	WO2011090741A3 TREATMENT OF TUMOR PROTEIN 63 (p63) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO p63
11/10/2011	WO2011088413A3 Lyophilized cake formulations
11/10/2011	WO2011065719A3 Topical composition for skin containing polysaccharide extract of red ginseng
11/10/2011	WO2011062443A3 Pharmaceutical composition for treating atopic dermatitis, containing lactobacillus, and pharmaceutical composition containing gold cultured together with said bacterium
11/10/2011	US20110275810 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
11/10/2011	US20110275708 Polycyclic compounds and methods related thereto
11/10/2011	US20110275684 Novel benzotriazole derivatives useful for the treatment of cns disorders
11/10/2011	US20110275680 Noxel oxime derivatives of 3, 5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same
11/10/2011	US20110275678 New Pyridine Derivatives as Leptin Receptor Modulator Mimetics
11/10/2011	US20110275677 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity
11/10/2011	US20110275671 Dihydroindolinone derivatives
11/10/2011	US20110275670 New Compounds VII
11/10/2011	US20110275669 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
11/10/2011	US20110275656 3H-Imidazo [4, 5-C] Pyridine- 6 -Carboxamides As Anti-Inflammatory Agents
11/10/2011	US20110275655 Pyrimidinecarboxamide derivatives as inhibitors of syk kinase
11/10/2011	US20110275645 Small Molecules for Inhibition of Protein Kinases
11/10/2011	US20110275639 C5aR ANTAGONISTS
11/10/2011	US20110275638 Piperazine derivatives and their use as leptin receptor modulators
11/10/2011	US20110275637 Piperazine derivatives and their use as leptin receptor modulators
11/10/2011	US20110275629 Pyridazino-pyridinone Compounds and Methods of Use
11/10/2011	US20110275628 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
11/10/2011	US20110275612 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
11/10/2011	US20110275611 Chemical compounds
11/10/2011	US20110275609 Bicyclic pyrazolo-heterocycles
11/10/2011	US20110275577 Methods of treating dermatologic, gynecologic, and genital disorders with caffeic acid analogs
11/10/2011	US20110275575 Peptide inhibitors of protein kinase c
11/10/2011	US20110275573 Tissue adhesive
11/10/2011	US20110275572 Nanocomposite Hyaluronic Acid-Clay Based Hydrogels
11/10/2011	US20110275562 Inhibition of gliadin peptides
11/10/2011	US20110274778 Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases
11/10/2011	US20110274776 Compositions comprising extracts of southernwood and an amine compound
11/10/2011	US20110274775 Extracts of southernwood and topical uses thereof
11/10/2011	US20110274756 Method and membrane for tissue regeneration
11/10/2011	US20110274727 Depigmenting topical compositions and their uses
11/10/2011	US20110274726 Chitosan foam medical devices and methods
11/10/2011	US20110274724 Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide
11/10/2011	US20110274704 Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
11/10/2011	US20110274699 ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF
11/10/2011	US20110274698 Immunomodulation Of Inflammatory Conditions Utilizing Follistatin-Like Protein-1 And Agents That Bind Thereto
11/10/2011	US20110274693 Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof
11/10/2011	US20110274667 Methods for obtaining cell populations from adipose tissue
11/10/2011	US20110274665 Dosage unit formulations of autologous dermal fibroblasts
11/10/2011	US20110274653 Dendritic cell immunoreceptors (dcir)-mediated crosspriming of human cd8+ t cells
11/10/2011	US20110274638 Oxoazetidine derivatives, process for the preparation thereof and use thereon in human medicine and in cosmetics

1 ... 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 ... 1065